AP15164PU-N uPA / PLAU (N-term) antibody

See related secondary antibodies

Search for all "uPA / PLAU"

0.4 ml / €380.00
Please visit the country specific website of Acris Antibodies or contact your local Distributor to buy this product.

Quick Overview

Rabbit anti Human, Mouse uPA / PLAU

AP15164PU-N

More Views

  • AP15164PU-N

Product Description for uPA / PLAU

Rabbit anti Human, Mouse uPA / PLAU.
Properties: (N-term)
Presentation: Purified
Product is tested for Paraffin Sections, Western blot / Immunoblot.

Properties for uPA / PLAU

Product Category Primary Antibodies
Target Category
Quantity 0.4 ml
Synonyms U-plasminogen activator, Urokinase, Urokinase-type plasminogen activator, Urokinase-type plasminogen activator chain B, Urokinase-type plasminogen activator long chain A, Urokinase-type plasminogen activator short chain A
Presentation Purified
Reactivity Hu, Ms
Applications P, WB
Clonality Polyclonal
Host Rabbit
Isotype Ig
Shipping to Worldwide
PDF datasheet View Datasheet
Manufacturer Acris Antibodies GmbH
Material safety datasheet MSDS for Polyclonal Antibodies (de)

Datasheet Extract

Immunogen
Swiss Prot Num:
P00749
Immunogen:
This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between aa 68-98 from the N-terminal region of human PLAU.
GeneID:
5328
Property N-term
Add. information Calculated MW: 48525 Da
Application ELISA: 1/1,000.
Western blotting: 1/100-1/500.
Immunohistochemistry: 1/50-1/100.
Background PLAU, a member of the peptidase family S1, is a potent plasminogen activator and is clinically used for therapy of thrombolytic disorders. PLAU specifically cleaves the Arg-|-Val bond in plasminogen to form plasmin. The protein is found in high and low molecular mass forms. Each consists of two chains, A and B. The high molecular mass form contains a long chain A. Cleavage occurs after residue 155 in the low molecular mass form to yield a short A1 chain. The protein is used in Pulmonary Embolism (PE) to initiates fibrinolysis. Structurally, PLAU contains 1 EGF-like domain and 1 kringle domain.
Caution This product is for research use only. Not for use in diagnostic or therapeutic procedures.
Concentration 0.25 mg/ml
General Readings
  1. Strausberg, R.L., et al., Proc. Natl. Acad. Sci. U.S.A. 99(26):16899-16903 (2002).
  2. Sperl, S., et al., Proc. Natl. Acad. Sci. U.S.A. 97(10):5113-5118 (2000).
  3. Turkmen, B., et al., Electrophoresis 18(5):686-689 (1997).
  4. Conne, B., et al., Thromb. Haemost. 77(3):434-435 (1997).
  5. Yoshimoto, M., et al., Biochim. Biophys. Acta 1293(1):83-89 (1996).
Storage Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
Avoid repeated freezing and thawing.
Shelf life: one year from despatch.
Format
Purification:
Protein G Chromatography, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS
Buffer System:
PBS with 0.09% (W/V) Sodium Azide as preservative.
State:
Liquid purified Ig fraction.
Purified
Specificity
Specificity:
This antibody recognizes Urokinase/PLAU (N-term).
Species:
Human and Mouse.
Gene ID 5328

Accessory Products

Proteins and/or Positive Controls

Proteins for uPA / PLAU (16 products)

Catalog No. Species Pres. Purity   Source  

uPA / PLAU (transcript variant 1)

uPA / PLAU Human > 80 %
Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps.
Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining.
HEK293 cells
20 µg / €680.00
  OriGene Technologies, Inc.

uPA / PLAU (transcript variant 1)

uPA / PLAU Human > 95 %
Preparation: .
Purity Detail: >95% as determined by SDS-PAGE and Coomassie blue staining.
HEK293 cells
10 µg / €139.00
  OriGene Technologies, Inc.

uPA / PLAU (HMW)

uPA / PLAU Human Purified >98% pure (SDS-PAGE). 95% high molecular weight. Purified by column chromatography Urine
  Acris Antibodies GmbH

uPA / PLAU (LMW Isoform)

uPA / PLAU Human Purified >98% pure (SDS-PAGE). >98% low molecular weight. Column chromatography Urine
  Acris Antibodies GmbH

uPA / PLAU

uPA / PLAU Human Purified > 90.0% as determined by SDS-PAGE. 
Contaminents: Free of: Hepatitis B surface antigen, Hepatitis C antibody and HIV I and II.
  Acris Antibodies GmbH

uPA / PLAU

uPA / PLAU Human Purified > 90.0% as determined by SDS-PAGE. 
Contaminents: Free of: Hepatitis B surface antigen, Hepatitis C antibody and HIV I and II.
  Acris Antibodies GmbH

uPA / PLAU

uPA / PLAU Human Purified > 90.0% as determined by SDS-PAGE. 
Contaminents: Free of: Hepatitis B surface antigen, Hepatitis C antibody and HIV I and II.
  Acris Antibodies GmbH

uPA / PLAU

uPA / PLAU Human Purified > 90 % Free of Hepatitis B surface antigen, Hepatitis C antibody and HIV I and II.
Purity is greater than 90.0% as determined by SDS-PAGE.
Urine
  Acris Antibodies GmbH

uPA / PLAU

uPA / PLAU Human Purified > 90 % Free of Hepatitis B surface antigen, Hepatitis C antibody and HIV I and II.
Purity is greater than 90.0% as determined by SDS-PAGE.
Urine
  Acris Antibodies GmbH

uPA / PLAU

uPA / PLAU Human Purified > 90 % Free of Hepatitis B surface antigen, Hepatitis C antibody and HIV I and II.
Purity is greater than 90.0% as determined by SDS-PAGE.
Urine
  Acris Antibodies GmbH

uPA / PLAU

uPA / PLAU Human 12.5% SDS-PAGE Stained with Coomassie Blue. in vitro transl.
  Abnova Taiwan Corp.

uPA / PLAU

uPA / PLAU Human 12.5% SDS-PAGE Stained with Coomassie Blue. in vitro transl.
  Abnova Taiwan Corp.

uPA / PLAU

uPA / PLAU Human
  Abnova Taiwan Corp.

uPA / PLAU

uPA / PLAU Human
  Abnova Taiwan Corp.

uPA / PLAU

uPA / PLAU Human
  Abnova Taiwan Corp.

uPA / PLAU

uPA / PLAU Human
  Abnova Taiwan Corp.

Positive controls for uPA / PLAU (1 products)

Catalog No. Species Pres. Purity   Source  

Urokinase Lysate

Western Blot: Urokinase Lysate [NBL1-14486] - Western Blot experiments. 
Left-Control; Right -Over-expression Lysate for PLAU
  Novus Biologicals Inc.
  • LinkedIn